Dissociation of T helper type 2 cytokine-dependent airway lesions from signal transducer and activator of transcription 6 signalling in experimental chronic asthma

Clinical and Experimental Allergy

Volumn 33, Issue 5, 2003, Pages 688-695

  Foster, P S ^a   Webb, D C ^a   Yang, M ^a   Herbert, C ^b   Kumar, R K ^b  

^a Biology and Environment   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Allergy; Cytokines; In vivo animal models; Inflammation; STAT6

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 13; INTERLEUKIN 14; INTERLEUKIN 4; INTERLEUKIN 5; METHACHOLINE; OVALBUMIN; STAT6 PROTEIN;

AIRWAY; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME IMMUNOASSAY; EOSINOPHIL; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MORPHOMETRICS; MOUSE; NONHUMAN; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RESPIRATORY EPITHELIUM; TH2 CELL;

ANIMALS; ASTHMA; BRONCHIAL PROVOCATION TESTS; CHRONIC DISEASE; CYTOKINES; FEMALE; IMMUNOGLOBULIN G; INTERLEUKIN-13; INTERLEUKIN-4; LYMPH NODES; MICE; MICE, INBRED BALB C; PULMONARY FIBROSIS; RESPIRATORY MUCOSA; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR; TH2 CELLS; TRANS-ACTIVATORS;

EID: 0038579646     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2003.01647.x     Document Type: Article

References (32)

1. Humbert M, Menz G, Ying S et al. The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. Immunol Today 1999; 20:528-33.
2. Humbert M, Corrigan CJ, Kimmitt P, Till SJ, Kay AB, Durham SR. Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am J Respir Crit Care Med 1997; 156:704-8.
3. Shi HZ, Xiao CQ, Zhong D et al. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics. Am J Respir Crit Care Med 1998; 157:204-9.
4. Kumar RK. Understanding airway wall remodeling in asthma: a basis for improvements in therapy? Pharmacol Ther 2001; 91:93-104.
5. Kumar RK, Foster PS. Modeling allergic asthma in mice: pitfalls and opportunities. Am J Respir Cell Mol Biol 2002; 27:267-72.
6. Temelkovski J, Hogan SP, Shepherd DP, Foster PS, Kumar RK. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 1998; 53:849-56.
7. Foster PS, Ming Y, Matthei KI, Young IG, Temelkovski J, Kumar RK. Dissociation of inflammatory and epithelial responses in a murine model of chronic asthma. Lab Invest 2000; 80:655-62.
8. Kumar RK, Herbert C, Yang M, Koskinen AML, McKenzie ANJ, Foster PS. Role of interleukin-13 in eosinophil accumulation and airway remodelling in a mouse model of chronic asthma. Clin Exp Allergy 2002; 32:1104-11.
9. Foster PS, Yang M, Herbert C, Kumar RK. CD4+ T-lymphocytes regulate airway remodeling and hyper-reactivity in a mouse model of chronic asthma. Lab Invest 2002; 82:455-62.
10. Kumar RK, Thomas PS, Seetoo DQ et al. Eotaxin expression by epithelial cells and plasma cells in chronic asthma. Lab Invest 2002; 82:495-504.
11. Takeda K, Kishimoto T, Akira S. STAT6: its role in interleukin 4-mediated biological functions. J Mol Med 1997; 75:317-26.
12. Yang M, Hogan SP, Henry PJ et al. Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-alpha chain and STAT6 independently of IL-5 and eotaxin. Am J Respir Cell Mol Biol 2001; 25:522-30.
13. Hamelmann E, Schwarze J, Takeda K et al. Non-invasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 1997; 156:766-75.
14. Hogan SP, Koskinen A, Matthaei KI, Young IG, Foster PS. Interleukin-5-producing CD4+ T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyper-reactivity, and lung damage in mice. Am J Respir Crit Care Med 1998; 157:210-8.
15. Webb DC, McKenzie ANJ, Koskinen AML, Yang M, Mattes J, Foster PS. Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyper-reactivity. J Immunol 2000; 165:108-13.
16. Kuperman D, Schofield B, Wills-Karp M, Grusby MJ. Signal transducer and activator of transcription factor 6 (STAT6)-deficient mice are protected from antigen-induced airway hyper-responsiveness and mucus production. J Exp Med 1998; 187:939-48.
17. Akimoto T, Numata F, Tamura M et al. Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT) 6-deficient mice. J Exp Med 1998; 187:1537-42.
18. Miyata S, Matsuyama T, Kodama T et al. STAT6 deficiency in a mouse model of allergen-induced airways inflammation abolishes eosinophilia but induces infiltration of CD8+ T cells. Clin Exp Allergy 1999; 29:114-23.
19. Tomkinson A, Kanehiro A, Rabinovitch N, Joetham A, Cieslewicz G, Gelfand EW. The failure of STAT6-deficient mice to develop airway eosinophilia and airway hyper-responsiveness is overcome by interleukin-5. Am J Respir Crit Care Med 1999; 160:1283-91.
20. Trifilieff A, El-Hasim A, Corteling R, Owen CE. Abrogation of lung inflammation in sensitized STAT6-deficient mice is dependent on the allergen inhalation procedure. Br J Pharmacol 2000; 130:1581-8.
21. Mathew A, MacLean JA, DeHaan E, Tager AM, Green FH, Luster AD. Signal transducer and activator of transcription 6 controls chemokine production and T helper cell type 2 trafficking in allergic pulmonary inflammation. J Exp Med 2001; 193:1087-96.
22. Tomkinson A, Duez C, Lahn M, Gelfand EW. Adoptive transfer of T cells induces airway hyperresponsiveness independently of airway eosinophilia but in a signal transducer and activator of transcription 6-dependent manner. J Allergy Clin Immunol 2002; 109:810-6.
23. Blease K, Schuh JM, Jakubzick C et al. STAT6-deficient mice develop airway hyper-responsiveness and peribronchial fibrosis during chronic fungal asthma. Am J Pathol 2002; 160:481-90.
24. Finkelman FD, Holmes J, Katona IM et al. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 1990; 8:303-33.
25. Hoshino M, Nakamura Y, Sim JJ. Expression of growth factors and remodelling of the airway wall in bronchial asthma. Thorax 1998; 53:21-7.
26. Laprise C, Laviolette M, Boutet M, Boulet LP. Asymptomatic airway hyper-responsiveness, relationships with airway inflammation and remodelling. Eur Respir J 1999; 14:63-73.
27. Hansen G, Berry G, DeKruyff RH, Umetsu DT. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999; 103:175-83.
28. Mattes J, Yang M, Siqueira A et al. IL-13 induces airways hyperreactivity independently of the IL-4Rα chain in the allergic lung. J Immunol 2001; 167:1683-92.
29. Hessel EM, van Oosterhout AJM, van Ark I et al. Development of airway hyper-responsiveness is dependent on interferon-γ and independent of eosinophil infiltration. Am J Respir Cell Mol Biol 1997; 16:325-34.
30. Aronica MA, Mora AL, Mitchell DB et al. Preferential role for NF-κB/Rel signaling in the type 1 but not type 2 T cell-dependent immune response in vivo. J Immunol 1999; 163:5116-24.
31. Fleming CM, He H, Ciota A, Perkins D, Finn PW. Administration of pentoxifylline during allergen sensitization dissociates pulmonary allergic inflammation from airway hyper-responsiveness. J Immunol 2001; 167:1703-11.
32. Leckie MJ, ten Brinke A, Khan J et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000; 356:2144-8.